Back to Search
HILARY LINTON, D.M.D.
D.M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1760820658Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (8)
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.
PMID 15596190·Urology·2004
8-other
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
PMID 15134977·Urology·2004
8-other
Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen.
PMID 15126794·J Urol·2004
8-other
Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.
PMID 15054080·Clin Chem·2004
8-other
Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml.
PMID 14634374·J Urol·2003
4-observational
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis.
PMID 12597929·Urology·2003
4-observational
Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease.
PMID 12560348·Clin Chem·2003
7-preclinical
A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.
PMID 11559576·Cancer Res·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4915 25TH AVE NE
SEATTLE, WA 98105 - Phone
- (206) 524-1600
Quick Facts
- NPI
- 1760820658
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile